| Drug Name | Neupogen (FILGRASTIM) |
|---|---|
| Drug Class |
Hematopoietic growth factor
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Hematology
Oncology
|
| Risk |
Risk of capillary leak syndrome in patients with cancer. |
| Dear Healthcare provider letter DHPC |
|